https://www.biospace.com/aprinoia-therapeutics-licenses-tau-pet-imaging-tracer-apn-1607-to-celgene
APRINOIA Therapeutics Licenses Tau PET Imaging Tracer APN-1607 to Celgene - BioSpace
Jan 2, 2019 - APRINOIA Therapeutics, a clinical-stage biotechnology company developing therapeutics and diagnostic imaging tools for neurodegenerative diseases announced...
tau pet
https://pmc.ncbi.nlm.nih.gov/articles/PMC10278956/
Impact of motion correction on [18F]-MK6240 tau PET imaging - PMC
PET imaging of tau deposition using [18F]-MK6240 often involves long acquisitions in older subjects, many of whom exhibit dementia symptoms. The resulting...
motion correctiontau petimpact